Total Payments
$56,581
2024 Payments
$1,777
Companies
45
Transactions
891
Medicare Patients
11,559
Medicare Billing
$1.3M
Payment Breakdown by Category
Other$34,130 (60.3%)
Food & Beverage$16,353 (28.9%)
Travel$6,002 (10.6%)
Education$95.23 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $34,130 | 17 | 60.3% |
| Food and Beverage | $16,353 | 852 | 28.9% |
| Travel and Lodging | $6,002 | 11 | 10.6% |
| Education | $95.23 | 11 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $41,506 | 59 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $1,763 | 87 | $0 (2024) |
| Amgen Inc. | $1,575 | 81 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,443 | 75 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,298 | 86 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,201 | 64 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $870.61 | 47 | $0 (2024) |
| Amarin Pharma Inc. | $867.57 | 51 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $802.72 | 66 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $584.36 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,777 | 84 | Novartis Pharmaceuticals Corporation ($373.74) |
| 2023 | $1,662 | 83 | Novartis Pharmaceuticals Corporation ($208.96) |
| 2022 | $2,003 | 108 | Amgen Inc. ($243.49) |
| 2021 | $2,418 | 120 | AstraZeneca Pharmaceuticals LP ($578.16) |
| 2020 | $1,567 | 85 | AstraZeneca Pharmaceuticals LP ($244.76) |
| 2019 | $1,766 | 110 | SANOFI-AVENTIS U.S. LLC ($278.41) |
| 2018 | $25,766 | 147 | Gilead Sciences, Inc. ($23,838) |
| 2017 | $19,622 | 154 | Gilead Sciences Inc ($17,631) |
All Payment Transactions
891 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.17 | General |
| Category: Cardiovascular | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: CARDIOLOGY | ||||||
| 11/06/2024 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: CARDIOLOGY | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $41.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: Transcatheter Heart Valves | ||||||
| 10/16/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.12 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | ONGLYZA (Drug) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/09/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.33 | General |
| 10/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: DIABETES | ||||||
| 09/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Cardiology | ||||||
| 09/23/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $24.04 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: DIABETES | ||||||
| 09/06/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $30.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Cardio-renal | ||||||
| 08/16/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: Not Applicable | ||||||
| 08/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,989 | 4,501 | $1.8M | $364,829 |
| 2022 | 23 | 2,667 | 3,991 | $1.4M | $292,909 |
| 2021 | 24 | 2,810 | 4,186 | $1.5M | $311,101 |
| 2020 | 22 | 3,093 | 4,682 | $1.7M | $346,452 |
Total Patients
11,559
Total Services
17,360
Medicare Billing
$1.3M
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 628 | 1,115 | $334,500 | $100,592 | 30.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 203 | 204 | $270,300 | $70,514 | 26.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 397 | 414 | $426,420 | $56,144 | 13.2% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 202 | 406 | $71,050 | $35,308 | 49.7% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 98 | 100 | $186,500 | $20,042 | 10.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 707 | 1,352 | $91,936 | $14,262 | 15.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 65 | 84 | $31,500 | $10,940 | 34.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 209 | 224 | $71,680 | $10,627 | 14.8% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 20 | 23 | $103,500 | $10,277 | 9.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 89 | 89 | $37,825 | $10,161 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 92 | 93 | $20,925 | $5,700 | 27.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 41 | $18,450 | $5,212 | 28.2% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 23 | 23 | $54,211 | $4,984 | 9.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 23 | 23 | $12,075 | $3,245 | 26.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 46 | $7,360 | $2,621 | 35.6% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 28 | 28 | $11,480 | $1,572 | 13.7% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 14 | 16 | $5,200 | $1,175 | 22.6% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 30 | 31 | $5,115 | $464.37 | 9.1% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 20 | 20 | $2,000 | $398.60 | 19.9% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 13 | 13 | $2,145 | $219.96 | 10.3% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 29 | 30 | $5,250 | $205.32 | 3.9% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 14 | 14 | $2,450 | $121.76 | 5.0% |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | Office | 2023 | 28 | 112 | $2,240 | $44.65 | 2.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 611 | 1,028 | $308,400 | $91,452 | 29.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 336 | 346 | $356,380 | $48,884 | 13.7% |
About Dr. Hector Malave, MD
Dr. Hector Malave, MD is a Cardiovascular Disease healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083620504.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hector Malave, MD has received a total of $56,581 in payments from pharmaceutical and medical device companies, with $1,777 received in 2024. These payments were reported across 891 transactions from 45 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($34,130).
As a Medicare-enrolled provider, Malave has provided services to 11,559 Medicare beneficiaries, totaling 17,360 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Atlanta, GA
- Active Since 08/01/2006
- Last Updated 09/25/2012
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1083620504
Products in Payments
- Ranexa (Drug) $41,269
- XARELTO (Drug) $1,298
- BRILINTA (Drug) $1,175
- ELIQUIS (Drug) $960.88
- MULTAQ (Drug) $905.86
- Vascepa (Drug) $867.57
- JARDIANCE (Drug) $825.66
- Repatha (Biological) $798.86
- Corlanor (Drug) $738.29
- PRADAXA (Drug) $617.35
- LEQVIO (Drug) $595.27
- LifeVest (Device) $584.36
- VERQUVO (Drug) $566.31
- NEXLETOL (Drug) $398.83
- Livalo (Drug) $389.09
- PRALUENT (Drug) $294.66
- ENTRESTO (Drug) $275.34
- Ozempic (Drug) $240.75
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $211.49
- Impella (Device) $201.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Atlanta
David Kandzari, Md, MD
Cardiovascular Disease — Payments: $1.3M
Cardiovascular Disease $1.3M
William Nicholson, Md, MD
Cardiovascular Disease — Payments: $1.2M
Cardiovascular Disease $1.2M
Dr. Joseph Miller, Md, MD
Cardiovascular Disease — Payments: $767,251
Cardiovascular Disease $767,251
Adam Greenbaum, M.d, M.D
Cardiovascular Disease — Payments: $377,582
Cardiovascular Disease $377,582
Randolph Martin, Md, MD
Cardiovascular Disease — Payments: $358,457
Cardiovascular Disease $358,457
Dr. Thomas Deering, Md, MD
Cardiovascular Disease — Payments: $237,098
Cardiovascular Disease $237,098